Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
Bacillus Calmette-Guerin (BCG) Vaccine
Bacillus Calmette-Guerin (BCG) Vaccine also called as Bacille de Calmette et Guérin or BCG, provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing tuberculosis (TB) disease. It is also used to treat bladder tumors or bladder cancer. Using BCG medicine, firstly the risks of taking the medicine must be weighed. This is a decision you and your doctor will make. For bacillus of calmette and guerin vaccine the following should be considered like Allergies, Pediatric, Geriatric, Pregnancy, Breast Feeding and Interactions with Food/Tobacco/Alcohol For a variable number of years after BCG vaccination, many people show a local skin reaction to the purified protein derived skin test (also called tuberculin skin test). Further testing for tuberculosis is often required in individuals given BCG vaccination in order to distinguish between a false-positive test result, in which an individual is not infected with tuberculosis, and a positive test result, in which an individual is infected with tuberculosis. Biological response modifiers are substances that have no direct antitumor effect but are able to trigger the immune system to indirectly affect tumors. BCG is thought to bring about an immune response in the bladder by triggering an inflammatory reaction in the bladder. This reaction brings disease-fighting white blood cells and cytokines to the bladder. The immune system cells then fight directly against the tumor cells. The cytokine response changes the environment in the bladder that may inhibit future tumor growth and progression. more
BCG symptoms of active TB are
•Weight loss
•Fever and night sweats
•Cough
•chest pains
•Weakness
Brand Names
TheraCys® BCG
TICE® BCG
BCG live
BCG vaccine
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Bacillus Calmette-Guerin (BCG) Vaccine
Bacillus Calmette-Guerin (BCG) Vaccine also called as Bacille de Calmette et Guérin or BCG, provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing tuberculosis (TB) disease. It is also used to treat bladder tumors or bladder cancer. Using BCG medicine, firstly the risks of taking the medicine must be weighed. This is a decision you and your doctor will make. For bacillus of calmette and guerin vaccine the following should be considered like Allergies, Pediatric, Geriatric, Pregnancy, Breast Feeding and Interactions with Food/Tobacco/Alcohol For a variable number of years after BCG vaccination, many people show a local skin reaction to the purified protein derived skin test (also called tuberculin skin test). Further testing for tuberculosis is often required in individuals given BCG vaccination in order to distinguish between a false-positive test result, in which an individual is not infected with tuberculosis, and a positive test result, in which an individual is infected with tuberculosis. Biological response modifiers are substances that have no direct antitumor effect but are able to trigger the immune system to indirectly affect tumors. BCG is thought to bring about an immune response in the bladder by triggering an inflammatory reaction in the bladder.
Market analysis : Global revenue for BCG vaccine was nearly $31.8 billion in 2011.This market is expected for BCG vaccine to increase from $55.6 billion in 2020. In the case of USA $13.3billion in 2011 ,but it will increase half of the percentage by the end of 2017. Geographically, south America, dominates the market followed by Europe. South America accounted for about 38% share in the BCG vaccine market in 2013 owing to the heavy investments by multinational companies in research and development of vaccine .
Upcoming conferences
Global Summit and Expo on Vaccines & Vaccination
Nov 30-Dec 02, 2015 San Francisco, USA
10th Euro Global Summit and Expo on Vaccines & Vaccination
June 16-18, 2016 Rome, Italy
11th Global Summit and Expo on Vaccines & Vaccination
Sept 12-14, 2016 Pheonix, USA
International Conference on Hepatitis Vaccines
Sept 26-28, 2016 Valencia, Spain
International Conferences on Tarvel Medicine and Vaccines
Aug 1-2, 2016 Seattle, USA
Children Vaccines World Congress
Oct 10-12, 2016 Kuala Lumpur, Malaysia
Annual Conference on Virulant HIV Vaccines
Oct 3-5, 2016 Miami, USA
12th Global Vaccines & Vaccination Summit and Expo
Oct 20-22, 2016 Dubai, UAE
5th International Conference and Exhibition on Immunology
Oct 24-26, 2016 Chicago, USA
International Conference on Cancer Immunology and Immunotherapy
July 28-30, 2016 Melborne, Australia
World Vaccine Congress 29-31 March 2016, USA
9th vaccine and ISV congress 18-20 Oct 2015 Seoul, South Korea
World Vaccine Congress Asia 2016 Singapore
Annual Conference on Vaccine Research April 18-20 2016 Baltimore USA
Relevant Associations and Societies
This page will be updated regularly.
This page was last updated on November 23, 2024
